Some HSV-based oncolytic virus vector candidates capitalize on the fact that, upon infection of tumor cells, the HSV-1 thymidine kinase (tk) is introduced into these malignant cells, rendering them susceptible to the cytotoxic effects of the prodrug ganciclovir (GCV). The gene discussed is TKT; the disease is neoplasm.